Edition:
United States

Tianjin Tianyao Pharmaceuticals Co Ltd (600488.SS)

600488.SS on Shanghai Stock Exchange

4.79CNY
22 May 2018
Change (% chg)

¥0.03 (+0.63%)
Prev Close
¥4.76
Open
¥4.74
Day's High
¥4.82
Day's Low
¥4.74
Volume
3,274,825
Avg. Vol
3,067,168
52-wk High
¥5.75
52-wk Low
¥4.16

Chart for

About

Tianjin Tianyao Pharmaceuticals Co., Ltd. is a China-based company principally engaged in the research, development and manufacturing of pharmaceutical products. The Company's primary products include corticosteroid bulk pharmaceutical chemicals (BPCs), amino acid BPCs and intermediate, such as dexamethasone, dexamethasone... (more)

Overall

Beta: 1.03
Market Cap(Mil.): ¥5,241.06
Shares Outstanding(Mil.): 1,091.89
Dividend: 0.04
Yield (%): 0.44

Financials

  600488.SS Industry Sector
P/E (TTM): 35.77 28.66 32.90
EPS (TTM): 0.13 -- --
ROI: 6.76 13.20 12.74
ROE: 5.61 14.95 14.64

BRIEF-Tianjin Tianyao Pharmaceuticals to sell 3.4 pct stake in trust firm

* Says it will sell 3.4 percent stake(33.7 million shares) in trust firm in Tianjin Property Rights Exchange

Mar 05 2018

BRIEF-Tianjin Tianyao Pharmaceuticals signs two API technical development commission contracts worth 3 mln yuan

* Says it and Tianjin Pharmaceuticals Research Institute Co., Ltd signs two technical development commission contracts of API glycyl-glutamine and glycyltyrosine worth 3 million yuan

Feb 14 2018

BRIEF-Tianjin Tianyao Pharmaceuticals production area of API passes FDA CGMP

* Says its API production area passes U.S. FDA CGMP and gets permission to continue selling in U.S. market

Nov 29 2017

Earnings vs. Estimates